Midline and off-midline wound closure methods after surgical treatment for pilonidal sinus.

Zhaolun Cai, Zhou Zhao, Qin Ma, Chaoyong Shen, Zhiyuan Jiang, Chunyu Liu, Chunjuan Liu, Bo Zhang
Author Information
  1. Zhaolun Cai: Department of General Surgery, Gastric Cancer Center, Research Laboratory of Tumor Epigenetics and Genomics for General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  2. Zhou Zhao: Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.
  3. Qin Ma: Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  4. Chaoyong Shen: Department of General Surgery, Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  5. Zhiyuan Jiang: Department of Plastic Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  6. Chunyu Liu: Department of Pharmacy, Evidence-based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
  7. Chunjuan Liu: Department of General Surgery, Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  8. Bo Zhang: Department of General Surgery, Gastric Cancer Center, Research Laboratory of Tumor Epigenetics and Genomics for General Surgery, West China Hospital, Sichuan University, Chengdu, China.

Abstract

BACKGROUND: Pilonidal sinus disease is a common and debilitating condition. Surgical treatment remains the mainstay for managing chronic disease, with options including midline and off-midline wound closure methods. However, the optimal approach remains uncertain. Recent developments in tension-free midline techniques require further exploration.
OBJECTIVES: To assess the effects of midline and off-midline wound closure methods for pilonidal sinus, and to determine the optimal off-midline flap procedures.
SEARCH METHODS: In June 2022, we searched the Cochrane Wounds Specialised Register, CENTRAL, MEDLINE, Embase, CINAHL Plus EBSCO, and clinical trials registries. We also scanned the reference lists of included studies, as well as reviews, meta-analyses, and health technology reports. We applied no language, publication date, or study setting restrictions.
SELECTION CRITERIA: We included parallel RCTs involving participants undergoing midline closure without flap techniques and off-midline closure for pilonidal sinus treatment. We excluded quasi-experimental studies and studies that enroled participants presenting with an abscess.
DATA COLLECTION AND ANALYSIS: We followed standard Cochrane methodology. The critical outcomes included wound healing (time to wound healing, proportion of wounds healed), recurrence rate, wound infection, wound dehiscence, time to return to work, and quality of life. We assessed biases in these outcomes utilising the Cochrane risk of bias 2 tool and appraised evidence certainty via the GRADE approach.
MAIN RESULTS: We included 33 studies with 3667 analysed participants. The median or average age of the participants across the included studies ranged from 21.0 to 34.2 years, with a predominant male representation. Geographically, the trials were primarily conducted in the Middle East. We identified nine intervention comparisons. In this abstract, we focus on and present the summarised findings for the three primary comparisons. Off-midline closure versus conventional midline closure Off-midline closure probably reduces the time to wound healing (mean difference (MD) -5.23 days, 95% confidence interval (CI) -7.55 to -2.92 days; 3 studies, 300 participants; moderate-certainty evidence). However, there may be little to no difference between the two methods in the proportion of wounds healed (100% versus 88.5%, risk ratio (RR) 1.13, 95% CI 0.92 to 1.39; 2 studies, 207 participants; very low-certainty evidence). Off-midline closure probably results in lower rates of recurrence (1.5% versus 6.8%, RR 0.22, 95% CI 0.11 to 0.45; 13 studies, 1492 participants; moderate-certainty evidence) and wound infection (3.8% versus 11.7%, RR 0.32, 95% CI 0.22 to 0.49; 13 studies, 1568 participants; moderate-certainty evidence), and may lower rates of wound dehiscence (3.9% versus 8.9%, RR 0.44, 95% CI 0.27 to 0.71; 11 studies, 1389 participants; low-certainty evidence). Furthermore, off-midline closure may result in a reduced time to return to work (MD -3.72 days, 95% CI -6.11 to -1.33 days; 6 studies, 820 participants; low-certainty evidence). There were no data available for quality of life. Off-midline closure versus tension-free midline closure Off-midline closure may reduce the time to wound healing (median 14 days in off-midline closure versus 51 days in tension-free midline closure; 1 study, 116 participants; low-certainty evidence) and increase wound healing rates at three months (94.7% versus 76.4%, RR 1.24, 95% CI 1.06 to 1.46; 1 study, 115 participants; low-certainty evidence), but may result in little to no difference in rates of recurrence (5.4% versus 7.8%, RR 0.69, 95% CI 0.30 to 1.61; 6 studies, 551 participants; very low-certainty evidence), wound infection (2.8% versus 6.4%, RR 0.44, 95% CI 0.16 to 1.17; 6 studies, 559 participants; very low-certainty evidence), and wound dehiscence (2.5% versus 3.0%, RR 0.82, 95% CI 0.17 to 3.84; 3 studies, 250 participants; very low-certainty evidence) compared to tension-free midline closure. Furthermore, off-midline closure may result in longer time to return to work compared to tension-free midline closure (MD 3.00 days, 95% CI 1.52 to 4.48 days; 1 study, 60 participants; low-certainty evidence). There were no data available for quality of life. Karydakis flap versus Limberg flap Karydakis flap probably results in little to no difference in time to wound healing compared to Limberg flap (MD 0.36 days, 95% CI -1.49 to 2.22; 6 studies, 526 participants; moderate-certainty evidence). Compared to Limberg flap, Karydakis flap may result in little to no difference in the proportion of wounds healed (80.0% versus 66.7%, RR 1.20, 95% CI 0.77 to 1.86; 1 study, 30 participants; low-certainty evidence), recurrence rate (5.1% versus 4.5%, RR 1.14, 95% CI 0.61 to 2.14; 9 studies, 890 participants; low-certainty evidence), wound infection (7.9% versus 5.1%, RR 1.55, 95% CI 0.90 to 2.68; 8 studies, 869 participants; low-certainty evidence), wound dehiscence (7.4% versus 6.2%, RR 1.20, 95% CI 0.41 to 3.50; 7 studies, 776 participants; low-certainty evidence), and time to return to work (MD -0.23 days, 95% CI -5.53 to 5.08 days; 6 studies, 541 participants; low-certainty evidence). There were no data available for quality of life.
AUTHORS' CONCLUSIONS: This Cochrane review examines the midline and off-midline wound closure options for pilonidal sinus, predominantly based on young adult studies. Off-midline flap procedures demonstrate there may be benefits over conventional midline closure for pilonidal sinus, with various off-midline flap techniques. When off-midline flap closures were compared to tension-free midline closure, low-certainty evidence indicated there may be improved wound healing and increased time to return to work for off-midline closure, whilst very low-certainty evidence indicated there may be no evidence of a difference in other outcomes. There may be no evidence of an advantage found amongst the off-midline techniques evaluated. The choice of either procedure is likely to be based on a clinician's preference, experience, patient characteristics, and the patients' preferences. To more accurately determine the benefits and potential harms of these closure techniques, further large-scale and meticulously-designed trials are essential. Specifically, there is a pressing need for more studies addressing the paediatric population, in addition to adult studies.

References

  1. Am J Surg. 2007 May;193(5):606-9; discussion 609 [PMID: 17434365]
  2. Health Info Libr J. 2019 Mar;36(1):73-90 [PMID: 30737884]
  3. Br J Surg. 2005 Sep;92(9):1081-4 [PMID: 16078300]
  4. Minerva Chir. 2020 Oct;75(5):355-364 [PMID: 32975384]
  5. Indian J Surg. 2013 Jun;75(3):192-4 [PMID: 24426425]
  6. J Pak Med Assoc. 2014 Nov;64(11):1270-3 [PMID: 25831644]
  7. Am J Surg. 2010 Jul;200(1):9-14 [PMID: 20637332]
  8. BMJ. 2021 Mar 29;372:n160 [PMID: 33781993]
  9. Int Wound J. 2004 Apr;1(1):10-7 [PMID: 16722893]
  10. Nurs Stand. 2007 Sep 5-11;21(52):48-56; quiz 58 [PMID: 17902446]
  11. World J Surg. 2013 Sep;37(9):2074-80 [PMID: 23732258]
  12. Control Clin Trials. 1986 Sep;7(3):177-88 [PMID: 3802833]
  13. J Pediatr Surg. 2019 Nov;54(11):2222-2233 [PMID: 30940347]
  14. JAMA. 2022 Dec 13;328(22):2252-2264 [PMID: 36511921]
  15. Surgery. 2016 Mar;159(3):749-54 [PMID: 26531235]
  16. Surgeon. 2019 Oct;17(5):300-308 [PMID: 30145045]
  17. Cochrane Database Syst Rev. 2022 Nov 24;11:ED000160 [PMID: 36421032]
  18. Tech Coloproctol. 2021 Dec;25(12):1269-1280 [PMID: 34176001]
  19. Int Sch Res Notices. 2014 Sep 07;2014:523015 [PMID: 27379300]
  20. Int Surg. 2015 May;100(5):870-7 [PMID: 26011208]
  21. BMJ. 2010 Mar 23;340:c332 [PMID: 20332509]
  22. Prague Med Rep. 2016;117(4):145-152 [PMID: 27930892]
  23. Stat Methods Med Res. 2018 Jun;27(6):1785-1805 [PMID: 27683581]
  24. Aust N Z J Surg. 1992 May;62(5):385-9 [PMID: 1575660]
  25. World J Surg. 2023 Sep;47(9):2296-2303 [PMID: 37204438]
  26. Adv Skin Wound Care. 2016 Oct;29(10):469-78 [PMID: 27632444]
  27. Surgeon. 2018 Oct;16(5):315-320 [PMID: 29699781]
  28. Clinics (Sao Paulo). 2015 May;70(5):350-5 [PMID: 26039952]
  29. Colorectal Dis. 2009 Sep;11(7):705-10 [PMID: 18637924]
  30. Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Nov 25;26(11):1008-1016 [PMID: 37974345]
  31. Ann Surg Treat Res. 2016 May;90(5):265-71 [PMID: 27186571]
  32. J Gastrointest Surg. 2018 Jan;22(1):133-137 [PMID: 28752401]
  33. Ann R Coll Surg Engl. 2019 Jan;101(1):21-29 [PMID: 30286636]
  34. Surgery. 2011 Nov;150(5):996-1001 [PMID: 21911239]
  35. Int J Colorectal Dis. 2021 Jul;36(7):1421-1431 [PMID: 33839888]
  36. BMC Med Res Methodol. 2014 Dec 19;14:135 [PMID: 25524443]
  37. Dis Colon Rectum. 2006 Feb;49(2):244-9 [PMID: 16322964]
  38. Dis Colon Rectum. 2013 Apr;56(4):491-8 [PMID: 23478617]
  39. World J Surg. 2012 Feb;36(2):431-5 [PMID: 22057753]
  40. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006213 [PMID: 20091589]
  41. Tech Coloproctol. 2014 Oct;18(10):863-72 [PMID: 24845110]
  42. Ann Coloproctol. 2019 May 22;35(6):313-318 [PMID: 31113167]
  43. BMJ. 1997 Sep 13;315(7109):629-34 [PMID: 9310563]
  44. J Wound Care. 2014 Dec;23(12):630-3 [PMID: 25492279]
  45. Dtsch Arztebl Int. 2019 Jan 7;116(1-2):12-21 [PMID: 30782310]
  46. BMJ. 2019 Aug 28;366:l4898 [PMID: 31462531]
  47. Am J Surg. 2010 Sep;200(3):318-27 [PMID: 20122682]
  48. Plast Surg Nurs. 2020 Apr/Jun;40(2):81-85 [PMID: 32459755]
  49. Med Care. 1992 Jun;30(6):473-83 [PMID: 1593914]
  50. Br J Surg. 1984 Feb;71(2):154-5 [PMID: 6692112]
  51. Langenbecks Arch Surg. 2021 Dec;406(8):2569-2580 [PMID: 33950407]
  52. Ann Ital Chir. 2019;90:574-579 [PMID: 31354153]
  53. Sci Rep. 2020 Aug 13;10(1):13720 [PMID: 32792519]
  54. J Pediatr Surg. 2019 Nov;54(11):2210-2221 [PMID: 30948198]
  55. Cochrane Database Syst Rev. 2024 Jan 16;1:CD015213 [PMID: 38226663]
  56. Colorectal Dis. 2023 Jan 12;: [PMID: 36636796]
  57. Tech Coloproctol. 2019 Dec;23(12):1173-1175 [PMID: 31754976]
  58. BJS Open. 2022 Mar 8;6(2): [PMID: 35289848]
  59. Colorectal Dis. 2020 Mar;22(3):319-324 [PMID: 31532869]
  60. Cureus. 2020 Mar 20;12(3):e7338 [PMID: 32313779]
  61. Glob J Health Sci. 2014 Sep 18;6(7 Spec No):18-22 [PMID: 25363174]
  62. Int J Colorectal Dis. 2021 Oct;36(10):2135-2145 [PMID: 33993341]
  63. Cochrane Database Syst Rev. 2022 May 20;5:CD013439 [PMID: 35593897]
  64. Surgery. 1997 Mar;121(3):258-63 [PMID: 9068667]
  65. Lancet. 1946 Oct 5;2(6423):484-6 [PMID: 20998923]
  66. Sci Rep. 2019 Oct 22;9(1):15111 [PMID: 31641150]
  67. Can J Surg. 2019 Feb 01;62(2):131-138 [PMID: 30697992]
  68. Health Policy. 1990 Dec;16(3):199-208 [PMID: 10109801]
  69. Sci Rep. 2018 Feb 15;8(1):3058 [PMID: 29449548]
  70. Langenbecks Arch Surg. 2018 Aug;403(5):547-554 [PMID: 30066108]
  71. Tech Coloproctol. 2014 Jan;18(1):29-37 [PMID: 23430349]
  72. Asian J Surg. 2017 Nov;40(6):434-437 [PMID: 27188235]
  73. Indian J Surg. 2012 Aug;74(4):305-8 [PMID: 23904719]
  74. Res Integr Peer Rev. 2023 Jun 20;8(1):6 [PMID: 37337220]
  75. Lancet. 1973 Dec 22;2(7843):1414-5 [PMID: 4128725]
  76. Int J Surg. 2011;9(4):343-6 [PMID: 21354343]
  77. Am J Surg. 2015 Oct;210(4):772-7 [PMID: 26138521]
  78. Surg Gynecol Obstet. 1981 Dec;153(6):842-4 [PMID: 7029758]
  79. Dis Colon Rectum. 2019 Feb;62(2):146-157 [PMID: 30640830]
  80. Eur J Surg. 1999 May;165(5):468-72 [PMID: 10391165]
  81. BMJ. 2020 Jan 16;368:l6890 [PMID: 31948937]
  82. Am J Surg. 2005 Sep;190(3):388-92 [PMID: 16105524]
  83. Am J Surg. 2011 Nov;202(5):568-73 [PMID: 21788003]
  84. ANZ J Surg. 2021 Jul;91(7-8):1582-1587 [PMID: 34101331]
  85. BMJ. 2003 Sep 6;327(7414):557-60 [PMID: 12958120]

MeSH Term

Young Adult
Child
Humans
Male
Adult
Pilonidal Sinus
Quality of Life
Wound Healing
Postoperative Complications
Wound Infection

Word Cloud

Created with Highcharts 10.0.0closureevidencestudiesparticipants0wound195%CIversuslow-certaintyoff-midlinemidlineRRflapdaysmaytime236healingsinustension-freeOff-midlinedifferencetechniquespilonidalincludedstudyreturnworkMDmethodsCochranerecurrenceinfectiondehiscencequalitylifemoderate-certaintylittle5%rates8%11result4%57comparedtreatmenttrialsoutcomesproportionwoundshealedprobably13227%9%dataavailable14KarydakisLimbergdiseaseremainsoptionsHoweveroptimalapproachdetermineproceduresraterisk33mediancomparisonsthreeconventional-5235592resultslower49844Furthermore-13061170%4201%basedadultbenefitsindicatedBACKGROUND:PilonidalcommondebilitatingconditionSurgicalmainstaymanagingchronicincludinguncertainRecentdevelopmentsrequireexplorationOBJECTIVES:assesseffectsSEARCHMETHODS:June2022searchedWoundsSpecialisedRegisterCENTRALMEDLINEEmbaseCINAHLPlusEBSCOclinicalregistriesalsoscannedreferencelistswellreviewsmeta-analyseshealthtechnologyreportsappliedlanguagepublicationdatesettingrestrictionsSELECTIONCRITERIA:parallelRCTsinvolvingundergoingwithoutexcludedquasi-experimentalenroledpresentingabscessDATACOLLECTIONANDANALYSIS:followedstandardmethodologycriticalassessedbiasesutilisingbiastoolappraisedcertaintyviaGRADEMAINRESULTS:3667analysedaverageageacrossranged2134yearspredominantmalerepresentationGeographicallyprimarilyconductedMiddleEastidentifiednineinterventionabstractfocuspresentsummarisedfindingsprimaryreducesmeanconfidenceinterval-7-2300two100%88ratio3920745149232156827711389reduced-372-6820reduce51116increasemonths947624064611569551165598284250longer0052486036526Compared80667786989090688692%4150776-05308541AUTHORS'CONCLUSIONS:reviewexaminespredominantlyyoungdemonstratevariousclosuresimprovedincreasedwhilstadvantagefoundamongstevaluatedchoiceeitherprocedurelikelyclinician'spreferenceexperiencepatientcharacteristicspatients'preferencesaccuratelypotentialharmslarge-scalemeticulously-designedessentialSpecificallypressingneedaddressingpaediatricpopulationadditionMidlinesurgical

Similar Articles

Cited By